Radiological Associates of Sacramento and Radiant Sage LLC Launch New Venture
Launched by Radiological Associates of Sacramento (RAS) and Radiant Sage LLC in August, Impact Corelab, Inc. provides imaging corelab services specializing in oncology and neurology clinical trials for drug and device sponsors and clinical research organizations (CROs) wanting to outsource without compromising the need for transparency and control. The new firm, wholly owned by Radiant Sage and RAS, delivers best-of-breed cloud-based clinical image management solutions and specialized therapeutic expertise to provide benefits that include shorter trials, reduced risk and cost savings.
Among the specific services Impact Corelab provides are:
·Trial design and management including site, study, reader and data management;
·Clinical imaging science;
·Regulatory services; and
·A comprehensive, integrated technology support platform
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
